Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Assets: 2024-2025

Historic Return on Assets for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -0.21%.

  • CG Oncology's Return on Assets fell 8.00% to -0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.21%, marking a year-over-year decrease of 8.00%. This contributed to the annual value of -0.18% for FY2024, which is N/A change from last year.
  • Per CG Oncology's latest filing, its Return on Assets stood at -0.21% for Q3 2025, which was down 18.05% from -0.18% recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Return on Assets ranged from a high of -0.11% in Q2 2024 and a low of -0.21% during Q3 2025.
  • Its 2-year average for Return on Assets is -0.15%, with a median of -0.14% in 2025.
  • Data for CG Oncology's Return on Assets shows a maximum YoY fell of 8bps (in 2025) over the last 5 years.
  • Over the past 2 years, CG Oncology's Return on Assets (Quarterly) stood at -0.13% in 2024, then declined by 8bps to -0.21% in 2025.
  • Its Return on Assets stands at -0.21% for Q3 2025, versus -0.18% for Q2 2025 and -0.14% for Q1 2025.